nitisinone

FDA Drug Profile — HARLIKU, ORFADIN

nitisinone is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand names including HARLIKU, ORFADIN. Available dosage forms: tablet, suspension.

Drug details

Generic Name
nitisinone
Brand Names
HARLIKU, ORFADIN
Application Number
NDA209449
Sponsor
Cycle Pharmaceuticals Ltd.
NDC Codes
5
Dosage Forms
TABLET, SUSPENSION
Routes
ORAL
Active Ingredients
NITISINONE

Indications and Usage

1 INDICATIONS & USAGE Nitisinone capsules are indicated for the treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine. Nitisinone is a hydroxy-phenylpyruvate dioxygenase inhibitor indicated for the treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine. (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.